14 Dec Odylia co-founder Luk Vandenberghe talks to Nature about bioengineered viruses and the Odylia (non)-business model.
Posted at 15:16h
in Press Releases
Researcher and entrepreneur Luk Vandenberghe thinks he can transport genes into cells much more efficiently by improving the viral vectors that carry them. He also describes how Odylia can leverage these new technologies to bring therapies for ultra-rare disorders into the clinic.